Works by MATHISEN, MICHAEL S.


Results: 7
    1
    2

    High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening Trial.

    Published in:
    Contemporary Oncology / Współczesna Onkologia, 2023, v. 27, n. 4, p. 217, doi. 10.5114/wo.2023.135246
    By:
    • Dziadziuszko, Rafal;
    • Peled, Nir;
    • Mok, Tony;
    • Peters, Solange;
    • Aix, Santiago Ponce;
    • Alatorre-Alexander, Jorge;
    • Vicuna, Brian D.;
    • Maclennan, Margaret;
    • Bhagawati-Prasad, Vijay;
    • Shagan, Sarah M.;
    • Schleifman, Erica;
    • Ruf, Thorsten;
    • Mathisen, Michael S.;
    • Gadgeel, Shirish M.
    Publication type:
    Article
    3
    4
    5
    6

    Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective case-control study.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 3, p. 198, doi. 10.1002/ajh.23371
    By:
    • Jabbour, Elias;
    • Mathisen, Michael S.;
    • Garcia-Manero, Guillermo;
    • Champlin, Richard;
    • Popat, Uday;
    • Khouri, Issa;
    • Giralt, Sergio;
    • Kadia, Tapan;
    • Chen, Julianne;
    • Pierce, Sherry;
    • Koca, Ebru;
    • Daver, Naval;
    • Tanaka, Maria;
    • Rondon, Gabriela;
    • Oran, Betul;
    • Parmar, Simrit;
    • Kantarjian, Hagop;
    • de Lima, Marcos
    Publication type:
    Article
    7